维普中文期刊产品整合服务
63篇 您的检索式:作者名="ROMMEL C"
    题名 作者 年代 出处 被引量
1采用不同导管和技术的去肾交感神经术治疗单纯收缩期高血压:一项随机试验结果显示文摘目前认为单纯收缩期高血压(isolated systolic hypertension,ISH)患者经去肾交感神经术(renal sympathetic denervation,RDN)后血压降低。此结论绝大多数来自单极射频导管消融的研究。但采用新的RDN的数据有限。研究者采用比较3种不同RDN方法的RADIOSOUND-HTN(采用不同RDN导管与技术治疗顽固性高血压患者的三臂随机试验)数据,探讨ISH与RDN反应的可能交互作用。Fengler K Rommel KP Lapusca R Blazek S Besler C Hartung P von Roeder M Kresoja KP Desch S Thiele H Lurz P 赵狄 练桂丽 2019中华高血压杂志2019,27,7:2
2PI3K5 and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond?显示文摘ROMMEL C CAMPS M JI H 2007Nat Rev Immunot2007,7,3:1
3PI3K+ and PI3K+/: partners in crime in inflammation in rheumatoid arthritis and beyond 显示文摘Rommel C Camps M Ji H 2007Nat Rev Immunol2007,7,3:1
4The heat shock protein 83 ( HSP83 ) is required for Raf-mediated signalling in Drosophila显示文摘van der Straten A Rommel C Dickson B et ai 1997EMBO J1997,16,8:1
5The heat shock protein 83 (Hsp83) is required for Raf-mediated signalling in Drosophila 显示文摘van der Straten A Rommel C Dickson B 1997EMBOJ1997,16,8:1
6Mediation of IGF - 1 -induced skeletal myotube hypertrophy by PI (3)K/Akt/mTOR and PI ( 3 ) K/Akt/GSK3 pathways 显示文摘ROMMEL C BODINE S C CLARKE B A 2001Nat Cell Biol2001,3,11:1
7Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways显示文摘Rommel C Bodine S C Clarke B A 2001Nat Cell Biol2001,3,11:1
8Mediation of IGF-l-induced skeletal myotube hypertrophy by PI (3) K/ Akt/mTOR and PI (3)K/Akt/GSK3 pathways 显示文摘ROMMEL C BODINE S C CLARKE B A 2001Nat Cell Biol2001,,11:1
9PI3K And cancer:lessons,challenges and opportunities显示文摘Fruman DA Rommel C 2014Nat Rev Drug Discov2014,13,2:1
10Targeting dual-specificity phosphatases:manipulating MAP kinase signalling and immune responses显示文摘Jeffrey KL Camps M Rommel C 2007Nat Rev Drug Discov2007,6,5:1
11Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme显示文摘Soda Y Myskiw C Rommel A 2013J Mol Med (Berl)2013,91,4:1
12Mediation of IGF-1 induced skeletal myotube hypertrophy by PI (3)K/Akt/mTOR and PI (3) K/Akt/GSK3 pathways显示文摘Rommel C Bodine SC Clarke BA 2001Nat Cell Biol2001,3,:1
13Differenti- ation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt显示文摘Rommel C Clarke BA Zimmermann S 1999Science1999,286,:1
14Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies:basis for a virus-like particle ELISA显示文摘Rommel O Dillner J Fligge C 2005J Med Virol2005,75,1:1
15Heparan sulfate proteoglycans interact exclusively with conformationally intact ttPV LI assemblies: basis for a virus-like particle ELISA显示文摘Rommel O Dillner J Fligge C 2005J Med Virol2005,75,1:1
16PI3K and cancer:lessons,challenges and opportunities显示文摘FRUMAN D A ROMMEL C 2014Nat Rev Drug Discov2014,13,2:1
17Mediation of IGF-I-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways显示文摘 Bodine SC Clarke BA 2001Nat Cell Biol2001,3,:1
18Differentiation stagespecific inhibition of the Raf-MEK-ERK pathway by Akt 显示文摘Rommel C Clarke BA Zimmermann S 1999Science1999,286,5445:1
19Strategies for chemokine antagonists as therapeutics显示文摘Proudfoot AEI Power CA Rommel C 2003Semin Immunol2003,15,1:1
20Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt显示文摘ROMMEL C CLARKE BA ZIMMERMANN S 1999Science1999,286,:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费